Discontinued — last reported Q3 '16
McKesson Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 0.4% to $277.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 71.0%, from $162.00M to $277.00M. Over 5 years (FY 2020 to FY 2025), Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) shows an upward trend with a 2.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $223.00M | $192.00M | $177.00M | $168.00M | $164.00M | $198.00M | $198.00M | $196.00M | $198.00M | $200.00M | $164.00M | $162.00M | $273.00M | $276.00M | $277.00M |
| QoQ Change | — | -13.9% | -7.8% | -5.1% | -2.4% | +20.7% | +0.0% | -1.0% | +1.0% | +1.0% | -18.0% | -1.2% | +68.5% | +1.1% | +0.4% |
| YoY Change | — | — | — | -24.7% | -14.6% | +11.9% | +17.9% | +19.5% | +0.0% | +1.0% | -16.3% | -18.2% | +36.5% | +68.3% | +71.0% |